2021
Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes
Kharbanda EO, Vazquez-Benitez G, DeSilva MB, Naleway AL, Klein NP, Hechter RC, Glanz JM, Donahue JG, Jackson LA, Sheth SS, Greenberg V, Panagiotakopoulos L, Mba-Jonas A, Lipkind HS. Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes. JAMA Network Open 2021, 4: e214340. PMID: 33818618, PMCID: PMC8022219, DOI: 10.1001/jamanetworkopen.2021.4340.Peer-Reviewed Original ResearchConceptsVaccine exposureHuman papillomavirus vaccineAdverse birth outcomesBirth outcomesSGA birthLive birthsPapillomavirus vaccinePreterm birthSpontaneous abortionCox proportional hazards regression modelProportional hazards regression modelsVaccine Safety DatalinkMean maternal ageMedical record reviewAge 45 yearsTime of pregnancyHazards regression modelsBirth defectsMajor structural birth defectsAge 26 yearsElectronic health recordsCohort studySingleton pregnanciesFinal cohortRecord review
2016
Variation in Hospital Intrapartum Practices and Association With Cesarean Rate
Lundsberg LS, Illuzzi JL, Gariepy AM, Sheth SS, Pettker CM, Lee HC, Lipkind HS, Xu X. Variation in Hospital Intrapartum Practices and Association With Cesarean Rate. Journal Of Obstetric Gynecologic & Neonatal Nursing 2016, 46: 5-17. PMID: 27886948, DOI: 10.1016/j.jogn.2016.07.011.Peer-Reviewed Original ResearchConceptsCesarean rateIntrapartum practicesIntrapartum interventionsIntrapartum careLow-risk womenLower cesarean ratesRegular reviewHospital cesarean rateCross-sectional surveyRank sum testKendall's tau-b correlation coefficientLiberal indicationsLabor inductionVaginal birthHospital variationNewborn careAntibody screenCesarean birthIntravenous lineObstetric servicesHospital characteristicsEligible hospitalsMassachusetts hospitalsFetal monitoringClinical staff